HPSE and breast cancer: The abundance of obesity-associated ECM accessory proteins HA and endotrophin is associated with poor disease outcomes in pan-subtype analyses of breast cancer patients, while expression of heparanase, which regulates ECM at the cell surface, is predictive of poor prognosis in HR+ breast cancer [54–56].